Study: Drug, devicemaker ties with academic ctrs common

A new study suggests that academic medical centers have tight relationships with pharmas and medical-device makers, perhaps tighter than previously thought. The study, which was done by researchers at the Massachusetts General Hospital Institute for Health Policy, found that 67 percent of teaching hospital departments and 60 percent of department heads had a compensated relationship with a drug or device maker. Meanwhile, about 65 percent of medical schools had such relationships.

The relationships between these companies and academic medical centers included consulting relationships, speaking opps, advisory board memberships and intellectual property partnerships--not to mention education program funding and support for residency and fellowship training.

To learn more about the study:
- read this Modern Healthcare article

Related Articles:
Psychiatrists getting largest pharma gifts. Report
NY bill would require pharmas to report MD gifts. Report
NH ban on prescription data use overturned. Report
Doctors weigh in on pros and cons of accepting drug/device freebies. Letters
States tighten screws on pharma marketers. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.